Market Place
Sourcing Support
Sebela Announces Data from Phase 3 Study of the Copper 175 mm² IUD
30 Oct 2023 //
PR NEWSWIRE
FDA Approves Sebela Pharmaceuticals` SUFLAVE™ A New Colonoscopy
22 Jun 2023 //
PR NEWSWIRE
Sebela Women`s Health Shares Findings from Cost Comparison of IUD
21 Mar 2023 //
PR NEWSWIRE
UK biotech hands off mid-stage C. difficile drug in up to $570M deal
27 Feb 2023 //
ENDPTS
Sebela Pharmaceuticals Announces New Division Named Sebela Women`s Health
15 Nov 2022 //
PRNEWSWIRE
Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights for Tegoprazan
28 Oct 2022 //
PRNEWSWIRE
Sebela Pharmaceuticals® Appoints Victor Parker as Chief Commercial Officer
24 Oct 2022 //
PRNEWSWIRE
Sebela Acquires Licensing Rights to Develop and Commercialize Tegoprazan
20 Oct 2022 //
PRNEWSWIRE
Sebela Announces U.S. Launch of SUTAB® Tablets, An Alternative to Liquid
05 Jan 2021 //
PRNEWSWIRE
Sebela Receives FDA Approval for SUTAB® Tablets for Colonoscopy Preparation
11 Nov 2020 //
PRNEWSWIRE
Brisdelle® (Paroxetine): Sebela Pharmaceuticals v. Actavis &Teva Pharmaceutical
28 Jun 2017 //
PATENT LITIGATION
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.